Latent Correlations Between Longitudinal Systemic Complement Factors and Geographic Atrophy Growth Rate
Purpose: Investigate associations between square root-transformed (SQRT) geographic atrophy (GA) growth rate and longitudinal systemic complement levels in non-neovascular AMD. Methods: Prospective longitudinal cohort study of patients with GA in the University of Colorado AMD Registry enrolled from August 2014 to September 2022, with ≥1month of follow-up imaging through April 2023. Systemic complement factor level ratios (Bb/Factor B, Ba/Factor B, Factor H, Factor I, C4b/C4, C3a/C3, C3b/C3, sC5b-9/C5) were collected approximately annually. SQRT GA growth rate was quantified on fundus autofluorescence. Correlations between GA growth rate and longitudinal biomarker levels were evaluated using a Bayesian hierarchical joint model. Results: One hundred fifty-five eyes from 88 patients were included. Average SQRT GA growth rate was 0.27mm/year over a mean of 3.3 years and was positively associated with female sex. Ba/Factor B (correlation [credible interval {CrI}]:0.35, 95% CrI: 0.02 to 0.64), and Bb/Factor B (0.20, 95% CrI: -0.086 to 0.48) demonstrated posterior distributions largely above zero, consistent with a positive association. Posterior distributions for Factor I (-0.08, 95% CrI: -0.35 to 0.20) and C3a/C3 (-0.14, 95% CrI: -0.44 to 0.18) were centered below zero, whereas those for Factor H (0.09, 95% CrI: -0.20 to 0.37) and sC5b-9/C5 (0.09, 95% Crl: -0.19 to 0.37) were centered above zero. Conclusions: Systemic alternative pathway biomarkers demonstrated the strongest positive associations with GA growth rate. The pattern of associations in this exploratory analysis supports a hypothesis-generating framework in which differences in alternative pathway regulation may be associated with heterogeneity in GA progression. Future larger studies are needed for external validation of this hypothesis-generating work.
Authors
- Benjamin Bearce (ORCID: https://orcid.org/0000-0002-1775-3899)
- Alan Gary Palestine (ORCID: https://orcid.org/0000-0001-6361-6767)
- Naresh Mandava (ORCID: https://orcid.org/0000-0003-3251-6469)
- Jayashree Kalpathy–Cramer (ORCID: https://orcid.org/0000-0001-8906-9618)
- Nicholas J. Cordaro (ORCID: https://orcid.org/0000-0001-7182-2130)
- Vernon Michael Holers (ORCID: https://orcid.org/0000-0002-5634-7746)
- Andrés Lisker-Cervantes (ORCID: https://orcid.org/0000-0001-6133-0116)
- Yoga Advaith Veturi (ORCID: https://orcid.org/0000-0001-6158-8408)
- Anne M. Lynch
- Talisa E. de Carlo (ORCID: https://orcid.org/0000-0002-3264-8982)
- Brandie D. Wagner (ORCID: https://orcid.org/0000-0002-2745-0103)
- Niranjan Manoharan (ORCID: https://orcid.org/0000-0001-5746-6854)
- Nathan C. Grove (ORCID: https://orcid.org/0000-0002-0375-0187)
- Talisa E. de Carlo Forest
- Steve McNamara
Institutions
- Colorado School of Public Health (US)
- University of Colorado Anschutz Medical Campus (US)
- University of Colorado Denver (US)
Publication Details
- Journal
- Investigative Ophthalmology & Visual Science
- Published
- 2026-10-27
- DOI
- https://doi.org/10.1167/iovs.67.12.69
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00